Alasdair L. Bamford
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: July 17, 2026
Which trial do we need? Treatment of severe measles.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 17, 2026
A Call for International Collaboration to Improve Definitions for the Surveillance of Congenital Syphilis.
Journal: The Pediatric infectious disease journal
Published: February 24, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.
Journal: Open forum infectious diseases
Published: January 26, 2026
Increasing Antiviral Usage in a UK Children's Hospital: A Call for Antiviral Stewardship.
Journal: The Pediatric infectious disease journal
Published: January 07, 2026
Correction: Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
Journal: PloS one
Published: December 16, 2025
Outcomes in Children With Enterovirus Meningitis in London, England: A Retrospective Multicenter Cohort Study, 2013-2023.
Journal: Open forum infectious diseases
Published: November 14, 2025
Identifying virulent avian paramyxovirus type-1: A paediatric case of progressive encephalitis diagnosed by clinical metagenomics with case series review.
Journal: IDCases
Published: October 23, 2025
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial.
Journal: The lancet. HIV
Published: September 03, 2025
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial.
Journal: The Lancet. Child & adolescent health
Published: August 28, 2025
How is mum? Think herpes in unwell mother and baby pairs: a multicentre case series.
Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: August 22, 2025
Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa.
Journal: Contemporary clinical trials
Published: August 21, 2025
Last Updated: 09/26/2026